http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1085864-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_36d2980d5a02d7dda5c7326bb5be4d16
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-555
filingDate 1999-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ae9cc726573307362853dbf3b3988c4
publicationDate 2001-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1085864-A1
titleOfInvention Method of hiv and hpv prophylaxis
abstract Human Immunodeficiency Virus and/or Human Papillomavirus infection can be prevented by the topical application of metallo-organic cobalt compounds according to formula (I) to the site of infection; wherein each A may be the same or different and is an alkyl group, a phenyl group or a substituted derivative of a phenyl group; wherein each Y may be the same or different and is hydrogen, an unbranched alkyl group, a halide or a group having the structure (a) wherein R is hydrogen, an alkoxide group, an alkyl group, or OH; wherein each B may be the same or different and each is hydrogen or an alkyl group; wherein each X may be the same or different and each is a water soluble group having weak to intermediate ligand filed strength; and Z<-> is a soluble, pharmaceutically acceptable negative ion. Metallo-organic cobalt compounds may also be used to disinfect liquids which contain Human Immunodeficiency Virus and/or Human Papillomavirus.
priorityDate 1998-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5049557-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9956552-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9606
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19649
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10566
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414648
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31200
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10566
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9606
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID12721
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395500
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID12721
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP25477

Total number of triples: 28.